Global /Canada /Healthcare /Biotechnology /OBI

Ondine Biomedical Inc.

OBI

• LSE: OBI • Delayed

12GBX -6%

0.1577 USD

As of 5 June 2026, Ondine Biomedical Inc. has a market cap of $87.13M USD, ranking #26548 globally and #784 in Canada. It ranks #2380 in the Healthcare sector, and #463 in the Biotechnology industry.

Global Rank

26548

Country Rank

784

Sector Rank

2380

Industry Rank

463

Key Stats

Market Cap

$87.13MUSD

64.94M GBP

Enterprise Value

$83.59MUSD

62.26M GBP

Revenue (TTM)

$1.58MUSD

1.18M GBP

EBITDA (TTM)

-$17.04MUSD

-12.69M GBP

Net Income (TTM)

-$17.16MUSD

-12.79M GBP

PS Ratio

55.1

PB Ratio

167.2

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Biotechnology

CEO

Carolyn Cross open_in_new

Employees

Founded

1996

Website

ondinebio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-6%	13%	21%	53%	22%	49%	41%	-32%	-75%

News

Markets

Exchange	Ticker	Price	Quotes
London Stock Exchange (LSE / LON) MIC: XLON PRIMARY	OBI Ondine Biomedical Inc Common Share ISIN: CA68234M2058 Shares Out.: Shares Outstanding: 518.367M¹ Shares Float: 334.45M² TV: TradingView: LSE: OBI SA: Stock Analysis: LON: OBI YF: Yahoo Finance: OBI.L GF: Google Finance: LON: OBI BA: Barron's: OBI MS: Morningstar: XLON: OBI	12 GBX	TV: TradingView: LSE: OBI SA: Stock Analysis: LON: OBI YF: Yahoo Finance: OBI.L GF: Google Finance: LON: OBI BA: Barron's: OBI MS: Morningstar: XLON: OBI
OTC Markets (OTCMKTS / OTC) MIC: OTCM	OBIMF Ondine Biomedical Inc Common Share ISIN: CA68234M2058 Shares Out.: Shares Outstanding: 443.233M¹ Shares Float: 263.712M² TV: TradingView: OTC: OBIMF SA: Stock Analysis: OTC: OBIMF YF: Yahoo Finance: OBIMF GF: Google Finance: OTCMKTS: OBIMF BA: Barron's: OBIMF MS: Morningstar: PINX: OBIMF	0.1400 USD	TV: TradingView: OTC: OBIMF SA: Stock Analysis: OTC: OBIMF YF: Yahoo Finance: OBIMF GF: Google Finance: OTCMKTS: OBIMF BA: Barron's: OBIMF MS: Morningstar: PINX: OBIMF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Ondine Biomedical Inc.

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.

Similar Companies

Industry: Biotechnology (Canada)

Name	Market Cap (USD) diff.	PE	Country
Aurinia Pharmaceuticals Inc. NASDAQ: AUPH	$1.99B 2K%	7.4	Canada
AbCellera Biologics Inc. NASDAQ: ABCL	$1.16B 1K%	-	Canada
Eupraxia Pharmaceuticals Inc. TSX: EPRX	$432.32M 600.89M CAD 396%	-	Canada
NervGen Pharma Corp. TSXV: NGEN	$295.12M 410.19M CAD 239%	-	Canada
Cybin Inc. NEO: CYBN	$254.07M 353.13M CAD 192%	-	Canada
Cardiol Therapeutics Inc. TSX: CRDL	$149.71M 208.08M CAD 72%	-	Canada

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 209K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 183K%	19.0	United States
argenx SE EBR: ARGX	$48.01B 41.39B EUR 55K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 51K%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 49K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.55B 33.71B CHF 49K%	37.2	Switzerland

chevron_leftBack